Annual Total Expenses
$437.29 M
+$95.17 M+27.82%
31 December 2023
Summary:
ANI Pharmaceuticals annual total expenses is currently $437.29 million, with the most recent change of +$95.17 million (+27.82%) on 31 December 2023. During the last 3 years, it has risen by +$213.24 million (+95.18%). ANIP annual total expenses is now at all-time high.ANIP Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$168.03 M
+$35.51 M+26.80%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly total expenses is currently $168.03 million, with the most recent change of +$35.51 million (+26.80%) on 30 September 2024. Over the past year, it has increased by +$51.59 million (+44.31%). ANIP quarterly total expenses is now at all-time high.ANIP Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +27.8% | +44.3% |
3 y3 years | +95.2% | +202.1% |
5 y5 years | +163.1% | +281.8% |
ANIP Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +95.2% | at high | +202.1% |
5 y | 5 years | at high | +163.1% | at high | +281.8% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ANI Pharmaceuticals Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $168.03 M(+26.8%) |
June 2024 | - | $132.51 M(+8.3%) |
Mar 2024 | - | $122.38 M(-0.5%) |
Dec 2023 | $437.29 M(+27.8%) | $122.94 M(+5.6%) |
Sept 2023 | - | $116.44 M(+12.9%) |
June 2023 | - | $103.11 M(+8.8%) |
Mar 2023 | - | $94.80 M(+6.3%) |
Dec 2022 | $342.12 M(+40.0%) | $89.22 M(+5.2%) |
Sept 2022 | - | $84.80 M(-0.4%) |
June 2022 | - | $85.18 M(+2.7%) |
Mar 2022 | - | $82.92 M(+1.8%) |
Dec 2021 | $244.31 M(+9.0%) | $81.43 M(+46.4%) |
Sept 2021 | - | $55.62 M(-0.3%) |
June 2021 | - | $55.78 M(+8.4%) |
Mar 2021 | - | $51.48 M(-8.9%) |
Dec 2020 | $224.04 M(+17.8%) | $56.48 M(+12.6%) |
Sept 2020 | - | $50.18 M(-16.1%) |
June 2020 | - | $59.78 M(+3.8%) |
Mar 2020 | - | $57.62 M(+9.6%) |
Dec 2019 | $190.12 M(+14.4%) | $52.56 M(+19.4%) |
Sept 2019 | - | $44.01 M(-2.3%) |
June 2019 | - | $45.06 M(-7.1%) |
Mar 2019 | - | $48.48 M(+6.1%) |
Dec 2018 | $166.22 M(+12.6%) | $45.68 M(+12.5%) |
Sept 2018 | - | $40.59 M(+1.5%) |
June 2018 | - | $40.01 M(+0.1%) |
Mar 2018 | - | $39.95 M(+2.4%) |
Dec 2017 | $147.61 M(+44.9%) | $39.00 M(+0.4%) |
Sept 2017 | - | $38.83 M(+2.8%) |
June 2017 | - | $37.77 M(+18.0%) |
Mar 2017 | - | $32.00 M(+5.9%) |
Dec 2016 | $101.86 M(+133.5%) | $30.22 M(-1.2%) |
Sept 2016 | - | $30.60 M(+17.1%) |
June 2016 | - | $26.14 M(+75.6%) |
Mar 2016 | - | $14.89 M(+26.5%) |
Dec 2015 | $43.62 M(+21.3%) | $11.77 M(+2.1%) |
Sept 2015 | - | $11.52 M(+3.8%) |
June 2015 | - | $11.10 M(+20.3%) |
Mar 2015 | - | $9.23 M(-10.1%) |
Dec 2014 | $35.96 M(+23.2%) | $10.27 M(+11.7%) |
Sept 2014 | - | $9.19 M(+0.9%) |
June 2014 | - | $9.11 M(+23.0%) |
Mar 2014 | - | $7.40 M(+4.7%) |
Dec 2013 | $29.18 M(+14.6%) | $7.07 M(+0.7%) |
Sept 2013 | - | $7.03 M(-29.2%) |
June 2013 | - | $9.93 M(+221.5%) |
Mar 2013 | - | $3.09 M(-44.9%) |
Dec 2012 | $25.47 M(-50.4%) | $5.60 M(+2.9%) |
Sept 2012 | - | $5.45 M(-26.2%) |
June 2012 | - | $7.38 M(+4.7%) |
Mar 2012 | - | $7.05 M(-17.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $51.36 M(+11.5%) | $8.51 M(-35.6%) |
Sept 2011 | - | $13.21 M(+0.5%) |
June 2011 | - | $13.15 M(-20.3%) |
Mar 2011 | - | $16.50 M(+24.0%) |
Dec 2010 | $46.08 M(+16.1%) | $13.31 M(+17.9%) |
Sept 2010 | - | $11.29 M(+10.3%) |
June 2010 | - | $10.24 M(-8.9%) |
Mar 2010 | - | $11.24 M(-56.6%) |
Dec 2009 | $39.68 M(+82.1%) | $25.91 M(+427.6%) |
Sept 2009 | - | $4.91 M(+3.7%) |
June 2009 | - | $4.74 M(+14.7%) |
Mar 2009 | - | $4.13 M(-24.5%) |
Dec 2008 | $21.79 M(+137.6%) | $5.47 M(-19.3%) |
Sept 2008 | - | $6.77 M(+22.3%) |
June 2008 | - | $5.54 M(+38.0%) |
Mar 2008 | - | $4.01 M(+71.4%) |
Dec 2007 | $9.17 M(-16.6%) | $2.34 M(+6.9%) |
Sept 2007 | - | $2.19 M(-18.9%) |
June 2007 | - | $2.70 M(+39.2%) |
Mar 2007 | - | $1.94 M(-52.8%) |
Dec 2006 | $11.00 M(+15.0%) | $4.11 M(+307.9%) |
Sept 2006 | - | $1.01 M(-59.2%) |
June 2006 | - | $2.47 M(-27.5%) |
Mar 2006 | - | $3.41 M(+80.4%) |
Dec 2005 | $9.56 M(-22.6%) | $1.89 M(-7.6%) |
Sept 2005 | - | $2.04 M(-25.1%) |
June 2005 | - | $2.73 M(-5.8%) |
Mar 2005 | - | $2.90 M(-32.1%) |
Dec 2004 | $12.34 M(+102.0%) | $4.26 M(+43.8%) |
Sept 2004 | - | $2.96 M(+12.5%) |
June 2004 | - | $2.63 M(+6.2%) |
Mar 2004 | - | $2.48 M(+46.7%) |
Dec 2003 | $6.11 M(-8.0%) | $1.69 M(+15.4%) |
Sept 2003 | - | $1.46 M(-10.0%) |
June 2003 | - | $1.63 M(+22.5%) |
Mar 2003 | - | $1.33 M(-41.0%) |
Dec 2002 | $6.64 M(+46.6%) | $2.25 M(+27.7%) |
Sept 2002 | - | $1.76 M(+17.4%) |
June 2002 | - | $1.50 M(+36.2%) |
Mar 2002 | - | $1.10 M(-23.4%) |
Dec 2001 | $4.53 M(+23.7%) | $1.44 M(-1.4%) |
Sept 2001 | - | $1.46 M(+60.6%) |
June 2001 | - | $909.80 K(+26.0%) |
Mar 2001 | - | $722.00 K(-25.7%) |
Dec 2000 | $3.66 M(+128.4%) | $972.10 K(+42.8%) |
Sept 2000 | - | $680.90 K(-54.5%) |
June 2000 | - | $1.50 M(+189.8%) |
Mar 2000 | - | $516.20 K(+58.2%) |
Dec 1999 | $1.60 M(-42.3%) | - |
June 1999 | - | $326.20 K |
Dec 1998 | $2.78 M | - |
FAQ
- What is ANI Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual total expenses year-on-year change?
- What is ANI Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly total expenses year-on-year change?
What is ANI Pharmaceuticals annual total expenses?
The current annual total expenses of ANIP is $437.29 M
What is the all time high annual total expenses for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual total expenses is $437.29 M
What is ANI Pharmaceuticals annual total expenses year-on-year change?
Over the past year, ANIP annual total expenses has changed by +$95.17 M (+27.82%)
What is ANI Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ANIP is $168.03 M
What is the all time high quarterly total expenses for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly total expenses is $168.03 M
What is ANI Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, ANIP quarterly total expenses has changed by +$51.59 M (+44.31%)